Cargando…
Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells
Endometrial cancers expressing estrogen and progesterone receptors respond to hormonal therapy. The disappearance of steroid hormone receptor expression is common in patients with recurrent disease, ultimately hampering the clinical utility of hormonal therapy. Here, we demonstrate for the first tim...
Autores principales: | Lin, Chiao-Yun, Chao, Angel, Wang, Tzu-Hao, Lee, Li-Yu, Yang, Lan-Yan, Tsai, Chia-Lung, Wang, Hsin-Shih, Lai, Chyong-Huey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312367/ https://www.ncbi.nlm.nih.gov/pubmed/27527851 http://dx.doi.org/10.18632/oncotarget.11048 |
Ejemplares similares
-
Palbociclib Promotes Dephosphorylation of NPM/B23 at Threonine 199 and Inhibits Endometrial Cancer Cell Growth
por: Lin, Chiao-Yun, et al.
Publicado: (2019) -
Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor α (ERα)
por: Tsai, Chia-Lung, et al.
Publicado: (2013) -
Stress-induced phosphoprotein-1 maintains the stability of JAK2 in cancer cells
por: Tsai, Chia-Lung, et al.
Publicado: (2016) -
Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling
por: Zhou, Yunxiao, et al.
Publicado: (2014) -
Massively parallel sequencing of endometrial lavage specimens for the detection of cancer-associated mutations in atypical and non-atypical endometrial hyperplasia
por: Weng, Cindy Hsuan, et al.
Publicado: (2022)